JW Pharmaceutical (XKRX:001060) Net Interest Margin (Bank Only) %

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

XKRX:001060 JW Pharmaceutical XKRX:001060
90 GF Score
Price ₩28,850.00
GF Value ₩32,148.31
Valuation Modestly Undervalued
View Full Analysis

What is JW Pharmaceutical Net Interest Margin (Bank Only) %?

Net Interest Margin (Bank Only) % only applies to banks.

XKRX:001060
90GF Score
JW Pharmaceutical XKRX:001060
Net Interest Margin (Bank Only) % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is JW Pharmaceutical (XKRX:001060) Overvalued in 2026?

Based on GuruFocus' analysis, JW Pharmaceutical stock appears to be undervalued. The current stock price of ₩28,850.00 is trading 10.3% below its estimated GF Value™ of ₩32,148.31. GuruFocus considers JW Pharmaceutical to be Modestly Undervalued.

Key valuation signals for XKRX:001060:

  • Net Interest Margin (Bank Only) %:
  • GF Value™: ₩32,148.31 vs. price of ₩28,850.00 (10.3% below fair value)
  • GF Score™: 90/100

No single metric tells the full story. See the XKRX:001060 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

JW Pharmaceutical Business Description

Address 2477, Nambusunhwan-ro, Seocho-gu, KOR
JW Pharmaceutical is active in the healthcare sector. It has been one of the leading companies in the pharmaceutical market on a global basis. Its original medicine and medical supply pipeline include Livalo, Thrupas, Sigmart and Actemra. It also develops low-protein and low-salt diet food for patients suffering from chronic renal insufficiency as well as general Pharmaceuticals and health care products.
90GF Score

Get the complete analysis for XKRX:001060

Net Interest Margin (Bank Only) % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₩28,850.00
Price
₩32,148.31
GF Value